SuperworthMcKesson profit margin MCK
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- 1.1%
- Operating margin, 12 months
- 1.6%
- Net margin on a year earlier
- +0.3 pts
- Peer median
- 15.2%
Over the twelve months to Jun 30, 2026, McKesson kept 1.1% of its revenue as net profit, with an operating margin of 1.6% and a gross margin of 3.6%.
Five years earlier its net margin was −1.8%.
The median for 10 healthcare stocks of a similar size is 15.2%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2026 | 1.2% | 1.5% | 3.6% |
| FY2025 | 0.9% | 1.2% | 3.7% |
| FY2024 | 1.0% | 1.3% | 4.2% |
| FY2023 | 1.3% | 1.6% | 4.5% |
| FY2022 | 0.4% | 0.8% | 5.0% |
| FY2021 | −1.9% | −2.1% | 5.1% |
| FY2020 | 0.4% | 1.1% | 5.2% |
| FY2019 | 0.0% | 0.4% | 5.5% |
| FY2018 | 0.0% | 0.4% | 5.4% |
| FY2017 | 2.6% | 3.6% | 5.7% |
| FY2016 | 1.2% | 1.9% | 6.0% |
| FY2015 | 0.8% | 1.7% | 6.4% |
| FY2014 | 0.9% | 1.8% | 6.1% |
| FY2013 | 1.1% | 1.9% | 5.6% |
| FY2012 | 1.1% | 1.8% | 5.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q1 FY27 | 1.1% | +0.3 pts | 1.6% | |
| Q4 FY26 | 1.2% | +0.3 pts | 1.5% | |
| Q3 FY26 | 1.1% | +0.3 pts | 1.4% | |
| Q2 FY26 | 1.0% | +0.3 pts | 1.4% | |
| Q1 FY26 | 0.8% | −0.1 pts | 1.2% | |
| Q4 FY25 | 0.9% | −0.1 pts | 1.2% | |
| Q3 FY25 | 0.8% | −0.2 pts | 1.2% | |
| Q2 FY25 | 0.8% | −0.4 pts | 1.0% | |
| Q1 FY25 | 0.9% | −0.4 pts | 1.2% | |
| Q4 FY24 | 1.0% | −0.3 pts | 1.3% | |
| Q3 FY24 | 1.0% | −0.2 pts | 1.2% | |
| Q2 FY24 | 1.2% | +0.4 pts | 1.5% |
Against its peers
Companies in Healthcare nearest McKesson's size, closest first, today.
| Company | Profit margin |
|---|---|
| MCKMcKesson | 1.1% |
| SYKStryker | 14.4% |
| CVSCVS Health | 1.2% |
| MDTMedtronic | 13.9% |
| BMYBristol-Myers Squibb | 18.9% |
| VRTXVertex Pharmaceuticals | 35.0% |
| HCAHCA Healthcare | 8.8% |
| ELVElevance Health | 2.5% |
| ISRGIntuitive Surgical | 25.5% |
| DHRDanaher | 15.9% |
| REGNRegeneron Pharmaceuticals | 27.9% |
| Peer median | 15.2% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on McKesson
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.